Podcast on Lorlatinib as a First-Line Treatment Option for Patients With ALK-Positive Metastatic NSCLC With Brain Metastasis

Podcast on Lorlatinib as a First-Line Treatment Option for Patients With ALK-Positive Metastatic NSCLC With Brain Metastasis

Article full text The above podcast audio represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: of, AdisRapid Journals on behalf, Liu, Geoffrey, Lam, Vincent K.
Format: Video
Sprache:eng
Schlagworte:
Cancer
Medicine
Oncology and Carcinogenesis not elsewhere classified
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Article full text The above podcast audio represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
DOI:10.6084/m9.figshare.23549364